|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 05, 2014 ) New York, NY -- Mirena Lawsuit News: As hundreds of women pursue Mirena IUD lawsuits for injuries allegedly caused by the long-acting contraceptive device, a new study has linked levonorgestrel-emitting IUDs to an increased risk of breast cancer. The research, which was published last month in the journal Obstetrics and Gynecology, found that women who used such an IUD to treat heavy menstrual bleeding were 19% more likely to develop breast cancer. The study followed 93,000 Finish women between the ages of 30 and 49 who had used a levonorgestrel IUD between 1994 and 2007.
(journals.lww.com/greenjournal/Abstract/publishahead/Cancer_Risk_in_Women_Using_the.99405.aspx, Obstetrics and Gynecology, July 7, 2014)
Levonorgestrel is the synthetic progestin released by Mirena. Out of the 93,000 women included in the study, 1,542 were diagnosed with breast cancer. Based on the incidence of the disease among women of the same age in the general population, the authors of the article had expected only 1,292 such diagnoses. However, they noted that that their research did not account for risk factors that may have predisposed women in this particular patient population to breast cancer, and called for additional studies of the issue.
The publication of this research comes as hundreds of women pursue Mirena IUD lawsuits that seek compensation for uterine perforations, ectopic pregnancies, and other personal injuries allegedly caused by the birth control device. In April, Bayer HealthCare Pharmaceuticals acknowledged in a Stockholder Letter that it had been named in at least 1,800 such claims. Court documents indicate that that a 924 Mirena lawsuits have been filed in a consolidated litigation underway in New Jersey’s Bergen County Superior Court. (In Re: Mirena Litigation; Case No. 297) Another 612 complaints that put forth similar allegations have been filed in the U.S. District Court, Southern District of New York.
(In re: Mirena IUD Products Liability Litigation, MDL No. 2434.)
(stockholders-newsletter-q1-2014.bayer.com/en/explanatory-notes.aspx#legalrisks, Bayer Healthcare Pharmaceuticals, April 24, 2014)
According to court records, all of these lawsuits allege that spontaneous migration of the Mirena IUD can result in a number of serious personal injuries, including:
Uterine perforations
Ectopic pregnancy
Miscarriage
Embedment of uterine wall
Cervical perforations
Infertility
Abscesses
Finally, plaintiffs in Mirena lawsuits accuse Bayer of overstating the benefits of the IUD and downplaying the potential for serious Mirena injuries. Among other things, they point to a 2009 warning letter the company received from the U.S. Food & Drug Administration (FDA) that reached similar conclusions about one of Bayer’s Mirena promotional campaigns.
(fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM197229.pdf, FDA, December 2009)
The Oliver Law Group is offering free Mirena IUD lawsuit reviews to women who may have been harmed by this birth control device. To learn more about filing a Mirena lawsuit, please contact our office by calling 800-939-7878 today.
About The Oliver Law Group P.C. And Filing A Mirena Lawsuit
Oliver Law Group P.C. is a different kind of law firm. One that focuses on the needs of the injured first. A compassionate law firm dedicated to fighting for the rights of victims and their families, and doing everything necessary to ensure those rights.
The experience of a large firm. The 1-on-1 dedication of a small firm. A reputation built on trust.
Experience. Dedication. Trust. Oliver Law Group P.C.
If you would like to learn more about filing a mirena lawsuit, turn to the law firm with the Experience, Dedication, and Trust you deserve. Contact the Oliver Law Group P.C. for your free case review by calling toll free 800-939-7878 today or visit Legal Action Now.
Oliver Law Group P.C.
Alyson Oliver
(800) 939-7878
info@oliverlg.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
